Publication: Evaluation of maternal serum folate, vitamin B12, and homocysteine levels and factor V Leiden, factor II g.20210G > A, and MTHFR variations in prenatally diagnosed neural tube defects
| dc.contributor.authors | Aydin, Hatip; Arisoy, Resul; Karaman, Ali; Erdogdu, Emre; Cetinkaya, Arda; Geckinli, B. Bilge; Simsek, Hasan; Demirci, Oya | |
| dc.date.accessioned | 2022-04-25T00:11:01Z | |
| dc.date.accessioned | 2026-01-10T20:30:07Z | |
| dc.date.available | 2022-04-25T00:11:01Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Background/aim: Neural tube defects (NTDs) are common congenital malformations that develop as a result of interactions between several genes and environmental factors. Many factors have been investigated in order to understand the etiology of NTDs, and many studies have identified folate intake as a common contributing factor. The exact etiology of the disease is still unknown. Materials and methods: In this study, we compared serum folate, vitamin B12, and homocysteine levels, along with common thrombophilia-related genetic variations, including factor V Leiden, factor II g.20210G>A, MTHFR c.677C>T, and MTHFR c.1298A>C, in 35 pregnant women with fetal NTDs and 38 pregnant women with healthy fetuses. Results: A significant difference in serum vitamin B12 level and factor V Leiden frequency was detected between the two groups. On the other hand, serum folate, homocysteine levels, and factor II g.20210G>A, MTHFR c.677C>T, and MTHFR c.1298A>C were not significantly different in the NTD group compared to the controls. Conclusion: These results indicate that vitamin B12 supplementation along with folate may help in lowering NTD frequency. In addition, this is the first study that provides evidence for a possible relationship between increased NTD risk and factor V Leiden. | |
| dc.identifier.doi | 10.3906/sag-1502-128 | |
| dc.identifier.eissn | 1303-6165 | |
| dc.identifier.issn | 1300-0144 | |
| dc.identifier.pubmed | 27511516 | |
| dc.identifier.uri | https://hdl.handle.net/11424/263819 | |
| dc.identifier.wos | WOS:000370271100038 | |
| dc.language | eng | |
| dc.publisher | TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY | |
| dc.relation.ispartof | TURKISH JOURNAL OF MEDICAL SCIENCES | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Folate | |
| dc.subject | vitamin B12 | |
| dc.subject | homocysteine | |
| dc.subject | thrombophilia | |
| dc.subject | neural tube defects | |
| dc.subject | METHYLENETETRAHYDROFOLATE REDUCTASE | |
| dc.subject | RISK-FACTOR | |
| dc.subject | GENE | |
| dc.subject | POLYMORPHISMS | |
| dc.subject | THROMBOPHILIA | |
| dc.subject | INCREASE | |
| dc.subject | MUTATION | |
| dc.subject | MOTHERS | |
| dc.subject | WOMEN | |
| dc.subject | C677T | |
| dc.title | Evaluation of maternal serum folate, vitamin B12, and homocysteine levels and factor V Leiden, factor II g.20210G > A, and MTHFR variations in prenatally diagnosed neural tube defects | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 494 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 489 | |
| oaire.citation.title | TURKISH JOURNAL OF MEDICAL SCIENCES | |
| oaire.citation.volume | 46 |
